Máster en Alimentación, Ética y Derecho

Cátedra UNESCO de Bioética

Contacto

 

"Recreational Genetics or Research Enterprise? Cloudy Consent Issues Arising from Direct-to-Consumer Genetic Testing"

Harvard Law

23andMe announced its $300 million partnership with GlaxoSmithKline late last month, a move that will allow the drug behemoth to develop drugs based on “deidentified” DNA and other information collected from the direct-to-consumer (DTC) genetic testing company’s five million customers.